Manufacture

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

The remarkable story of gene therapy drug development during the 1990s and early 2000s.

Pharma sponsors are increasingly looking to CDMOs to help reduce risk and push projects forward.

Cytiva is working to address increasing demand for flexibility and component interchangeability.

Demand for gene therapies is rising, so all the more reason to better understand the properties of their delivery devices

Company claims new facility will be one of the largest single-use manufacturing sites in the world.

Our free eBook showcases content on bioprocess scale up, biosimilars, primary packaging considerations, and more.

Can we make clinical trials more accessible through virtual means?

Sartorius shares its vision for better, faster, and cheaper bioprocessing.

Current approaches to R&D tech investment are not helping life science companies. How can the situation be improved?